Jürgen Eberle

13PUBLICATIONS
20CO-AUTHORS
Molecular targetsCardiology (incl. cardiovascular diseases)ChemotherapyMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 11, 2025
Correction: Sumarni et al. Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP. Cells 2021, 10, 987.

Uly Sumarni, Ulrich Reidel, Jürgen Eberle

|Jan 08, 2025
Correction: Hazzan et al. Thymic Stromal Lymphopoietin Interferes with the Apoptosis of Human Skin Mast Cells by a Dual Strategy Involving STAT5/Mcl-1 and JNK/Bcl-xL. Cells 2019, 8, 829.

Tarek Hazzan, Jürgen Eberle, Margitta Worm

|Mar 28, 2024
Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-xL/Bcl-w Inhibitors.

Zhe Peng, Bernhard Gillissen, Antje Richter

|May 27, 2023
Cannabinoids Reduce Melanoma Cell Viability and Do Not Interfere with Commonly Used Targeted Therapy in Metastatic Melanoma In Vivo and In Vitro.

Georg Richtig, Melanie Kienzl, Sonja Rittchen

|Mar 11, 2023
Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins.

Zhe Peng, Bernhard Gillissen, Antje Richter

|Oct 27, 2022
Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression.

Uly Sumarni, Jiaqi Zhu, Tobias Sinnberg

Pageof 3

Frequent Collaborators

2 joint publications

Henry Fechner

2 joint publications

Bernhard Gillissen

2 joint publications

Tobias Sinnberg

1 joint publications

Zina Sarif